6-{[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]methyl}-N-(4-methylphenyl)-1,3,5-triazine-2,4-diamine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并间二氧杂环戊烯类
• 英文名称: 6-{[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]methyl}-N-(4-methylphenyl)-1,3,5-triazine-2,4-diamine
• 英文别名: 6-[[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]methyl]-2-N-(4-methylphenyl)-1,3,5-triazine-2,4-diamine
• 化学式: C₂₃H₂₇N₇O₂
• 分子量: 433.5
• InChiKey: UYYURNADXNBWIN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  32
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  102
• 氢给体数：
  2
• 氢受体数：
  9

文献信息

• Heteroaryl compounds and their use
  申请人：Minoryx Therapeutics S.L.

  公开号：US11174242B2

  公开（公告）日：2021-11-16

  The application is directed to compounds of formula (I): and their salts and solvates, wherein R1, R2, R3, A1, A2, A3, and n are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of a lysosomal storage disease, such as Gaucher's, and other diseases or disorders that are synucleinopathies.

  本申请涉及式（I）化合物：及其盐类和溶解物，其中 R1、R2、R3、A1、A2、A3 和 n 如说明书所述，还涉及其制备方法、包含这些化合物的药物组合物，以及将其用于治疗和/或预防溶酶体贮积疾病（如戈谢病）和属于突触核蛋白病的其他疾病或紊乱的用途。
• HETEROARYL COMPOUNDS AND THEIR USE
  申请人：Minoryx Therapeutics S.L.

  公开号：US20190337922A1

  公开（公告）日：2019-11-07

  The application is directed to compounds of formula (I): and their salts and solvates, wherein R 1 , R 2 , R 3 , A 1 , A 2 , A 3 , and n are as set forth in the specification, as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of a lysosomal storage disease, such as Gaucher's, and other diseases or disorders that are synucleinopathies.